slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 17,401-17,430
Pages 819
Rows per page 30
Slide function
17,401-17,430 of 24,547
04
The slide uses a timeline-like structure to show the transition from capital-intensive building to operational execution.AbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · NeedLoop · Why Now1 hit
06
The slide uses a side-by-side comparison of two antibody mechanisms of action.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Rising Success1 hit
12
Uses a visual metaphor of coins growing plants to represent growth.Azerion | Results Presentation Deck | 24 slides · Azerion
Conference presentation Investor relations Loop · Logic Chain1 hit
14
Uses a visual metaphor of growing plants on coin stacks to represent growth and investment.Azerion | Results Presentation Deck | 24 slides · Azerion
Conference presentation Investor relations Loop · Logic Chain1 hit
07
The slide uses a split-layout design with a numbered callout (2) to indicate this is part of a broader strategic argument.Blackwells Capital | Activist Presentation Deck | 22 slides · Blackwells Capital
Activist deck Activist investor 1 hit
13
The central Venn diagram uses four overlapping circles to represent the synergy between Leadership Connections, Strategic Alliances, Best Service Level, and Captive Insurance Deposits.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
11
The slide uses a 'flywheel' or 'platform leverage' architecture to show how core assets support multiple segments.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Beat · Business ModelLoop · Quick Win Big Bet1 hit
13
The funnel structure implies a progression of depth and time commitment for learners.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
12
The slide uses a numbered list format to outline strategic priorities for 2024.Crocs | Results Presentation Deck | 41 slides · Crocs
Conference presentation Investor relations 1 hit
04
The slide uses a 'ribbon' layout to highlight four key pillars of the company's methodology.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
12
Slide 12 of the deck.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations Beat · ProductLoop · Mece Breakdown1 hit
15
The slide uses a split-screen layout to contrast in vitro IC50 data with in vivo tumor regression data.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
16
Includes technical definitions of selectivity index and experimental conditions for Wistar Han rats.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
24
The slide uses a three-column layout to segment the market by treatment line (3L+, 2L, 1L) and define the specific clinical opportunity for each.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
29
The slide uses three distinct chart types to demonstrate competitive advantages in potency, PK, and selectivity.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
38
The slide uses a 'Target Product Profile' framework to summarize the drug's key characteristics.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
39
Includes three distinct preclinical assay results: In Vitro Activity, Selectivity Index, and Brain Penetrance.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
16
Includes a formula for Selectivity index and a legend for various compound mutations.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
25
The slide uses a three-column layout to segment the market by treatment line (3L+, 2L, 1L) and contrast current standards of care with the proposed solution's benefits.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
Includes specific pharmacological data points for NVL-520 vs competitors like Crizotinib, Entrectinib, Lorlatinib, Taletrectinib, and Repotrectinib.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
39
The slide uses a 'ribbon' style callout box on the right for key product attributes.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
40
The slide uses three distinct chart types to demonstrate superiority in three key pharmacological areas.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
07
Includes a biological pathway diagram and a dose-response curve showing target validation.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide presents experimental evidence (Western blot) supporting the mechanism of action for NXP800 in ARID1a-deficient cancer cells.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide uses a structural biology mechanism of action (MOA) comparison to demonstrate competitive advantage.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
18
Includes a biological pathway diagram and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Voice Of Customer1 hit
20
Includes two distinct experimental setups: in vitro proliferation assays and in vivo bioluminescence imaging (BLI) tumor growth studies.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
05
The slide uses a dual-flywheel framework to represent the integration between member engagement and provider collaboration.Oscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
13
The slide uses a circular process diagram to represent the platform's core functions.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Solution1 hit
04
Talkspace | Investor Conference Presentation Deck | 13 slidesTalkspace | Investor Conference Presentation Deck | 13 slides · Talkspace
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit